We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biosimilar Guidance Silent On Industry's Biggest Questions

Law360, New York (February 10, 2012, 9:27 PM EST) -- The U.S. Food and Drug Administration's newly released guidance on how it will review biosimilars was a relief to an industry that's been waiting two years for clarity. But experts say...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.